Concomitant nondermatologic adverse events in patients who develop immunotherapy-induced subacute cutaneous lupus erythematosus

Dermatol Ther. 2022 Dec;35(12):e15906. doi: 10.1111/dth.15906. Epub 2022 Oct 18.

Authors

Rasika Reddy¹, Andrew Park¹, Travis Vandergriff¹, Benjamin F Chong¹

Affiliation

¹ Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

PMID: 36200592
DOI: 10.1111/dth.15906

No abstract available

Publication types

Letter

MeSH terms

Humans
Immunotherapy / adverse effects
Lupus Erythematosus, Cutaneous* / chemically induced
Lupus Erythematosus, Cutaneous* / diagnosis
Lupus Erythematosus, Cutaneous* / therapy